However, IL-18BP levels have been shown to be high in sera of patients with ovarian [135], non-small cell lung cancer [101] and prostate cancer [136], as well as in tumor tissue of melanoma, breast, head and neck, gastric, ovarian and prostate cancers [101,135,136]. Here, IL18BP is linked to prostate carcinoma.